dn 1417 has been researched along with naloxone in 2 studies
| Studies (dn 1417) | Trials (dn 1417) | Recent Studies (post-2010) (dn 1417) | Studies (naloxone) | Trials (naloxone) | Recent Studies (post-2010) (naloxone) |
|---|---|---|---|---|---|
| 94 | 2 | 0 | 20,134 | 1,257 | 3,321 |
| Protein | Taxonomy | dn 1417 (IC50) | naloxone (IC50) |
|---|---|---|---|
| Cytochrome P450 2D6 | Homo sapiens (human) | 2 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.043 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0219 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0019 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0019 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.0397 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.1896 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.05 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.0795 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.0154 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0089 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.0055 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iriuchijima, T; Ishihara, H; Kobayashi, S; Michimata, T; Mori, M; Yamada, M | 1 |
| Bhargava, HN; Matwyshyn, GA | 1 |
2 other study(ies) available for dn 1417 and naloxone
| Article | Year |
|---|---|
An analogue of thyrotropin-releasing hormone, DN1417, decreases naloxone binding in the rat brain.
Topics: Animals; Brain; Chromatography, High Pressure Liquid; Corpus Striatum; Hormones; Hypothalamus; Male; Naloxone; Rats; Rats, Inbred Strains; Receptors, Opioid; Thyrotropin-Releasing Hormone; Tissue Distribution | 1989 |
Comparative effects of thyrotropin releasing hormone, MK-771 and DN-1417 on morphine abstinence syndrome.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anticonvulsants; Body Temperature; Body Weight; Male; Mice; Morphine Dependence; Naloxone; Substance Withdrawal Syndrome; Thiazolidines; Thyrotropin-Releasing Hormone; Time Factors | 1985 |